|
| 36993741 | Targeted gene expression profiling predicts meningioma outcomes and radiotherapy responses. | Res Sq | 2023 |
| 35849035 | Depatuxizumab mafodotin in EGFR-amplified newly diagnosed glioblastoma: A phase III randomized clinical trial. | Neuro Oncol | 2023 |
| 35657335 | Low-risk meningioma: Initial outcomes from NRG Oncology/RTOG 0539. | Neuro Oncol | 2023 |
| 37944590 | Targeted gene expression profiling predicts meningioma outcomes and radiotherapy responses. | Nat Med | 2023 |
| 38024244 | NRG/RTOG 0837: Randomized, phase II, double-blind, placebo-controlled trial of chemoradiation with or without cediranib in newly diagnosed glioblastoma. | Neurooncol Adv | 2023 |
| 35731991 | Joint Final Report of EORTC 26951 and RTOG 9402: Phase III Trials With Procarbazine, Lomustine, and Vincristine Chemotherapy for Anaplastic Oligodendroglial Tumors. | J Clin Oncol | 2022 |
| 34589661 | Long-Term Report of a Comprehensive Molecular and Genomic Analysis in NRG Oncology/RTOG 0424: A Phase II Study of Radiation and Temozolomide in High-Risk Grade II Glioma. | JCO Precis Oncol | 2021 |
| 33957633 | BRCA1 Protein Expression Predicts Survival in Glioblastoma Patients from an NRG Oncology RTOG Cohort. | Oncology | 2021 |
| 33515019 | Neurocognitive, symptom, and health-related quality of life outcomes of a randomized trial of bevacizumab for newly diagnosed glioblastoma (NRG/RTOG 0825). | Neuro-Oncology | 2021 |
| 32706640 | Comprehensive Genomic Analysis in NRG Oncology/RTOG 9802: A Phase III Trial of Radiation Versus Radiation Plus Procarbazine, Lomustine (CCNU), and Vincristine in High-Risk Low-Grade Glioma. | J Clin Oncol | 2020 |
| 32251755 | Phase 2 Study of a Temozolomide-Based Chemoradiation Therapy Regimen for High-Risk, Low-Grade Gliomas: Long-Term Results of Radiation Therapy Oncology Group 0424. | International Journal of Radiation Oncology Biology Physics | 2020 |
| 31786276 | High-risk Meningioma: Initial Outcomes From NRG Oncology/RTOG 0539. | Int J Radiat Oncol Biol Phys | 2020 |
| 29404979 | NRG oncology RTOG 9006: a phase III randomized trial of hyperfractionated radiotherapy (RT) and BCNU versus standard RT and BCNU for malignant glioma patients. | J Neurooncol | 2018 |
| 29126203 | A randomized phase II study of everolimus in combination with chemoradiation in newly diagnosed glioblastoma: results of NRG Oncology RTOG 0913. | Neuro Oncol | 2018 |
| 29462493 | Short delay in initiation of radiotherapy for patients with glioblastoma-effect of concurrent chemotherapy: a secondary analysis from the NRG Oncology/Radiation Therapy Oncology Group database. | Neuro-Oncology | 2018 |
| 28097324 | Molecular-Based Recursive Partitioning Analysis Model for Glioblastoma in the Temozolomide Era: A Correlative Analysis Based on NRG Oncology RTOG 0525. | JAMA Oncol | 2017 |
| 28619981 | Ibrutinib Unmasks Critical Role of Bruton Tyrosine Kinase in Primary CNS Lymphoma. | Cancer Discov | 2017 |
| 27050206 | Radiation plus Procarbazine, CCNU, and Vincristine in Low-Grade Glioma. | N Engl J Med | 2016 |
| 27022122 | Phase I and II Study of Induction Chemotherapy With Methotrexate, Rituximab, and Temozolomide, Followed By Whole-Brain Radiotherapy and Postirradiation Temozolomide for Primary CNS Lymphoma: NRG Oncology RTOG 0227. | J Clin Oncol | 2016 |
| 25758746 | Phase 2 trial of dasatinib in target-selected patients with recurrent glioblastoma (RTOG 0627). | Neuro Oncol | 2015 |
| 25832688 | Phase 1/2 trials of Temozolomide, Motexafin Gadolinium, and 60-Gy fractionated radiation for newly diagnosed supratentorial glioblastoma multiforme: final results of RTOG 0513. | International Journal of Radiation Oncology Biology Physics | 2015 |
| 25688120 | Variation over time and interdependence between disease progression and death among patients with glioblastoma on RTOG 0525. | Neuro-Oncology | 2015 |
| 24552317 | A randomized trial of bevacizumab for newly diagnosed glioblastoma. | N Engl J Med | 2014 |
| 25304947 | Secondary analysis of RTOG 9508, a phase 3 randomized trial of whole-brain radiation therapy versus WBRT plus stereotactic radiosurgery in patients with 1-3 brain metastases; poststratified by the graded prognostic assessment (GPA). | International Journal of Radiation Oncology Biology Physics | 2014 |
| 24419119 | Effect of the addition of chemotherapy to radiotherapy on cognitive function in patients with low-grade glioma: secondary analysis of RTOG 98-02. | J Clin Oncol | 2014 |
| 24752060 | Reply to M.C. Chamberlain. | J Clin Oncol | 2014 |
| 23725999 | RTOG 0913: a phase 1 study of daily everolimus (RAD001) in combination with radiation therapy and temozolomide in patients with newly diagnosed glioblastoma. | International Journal of Radiation Oncology Biology Physics | 2013 |
| 24252135 | Predictive value of tumor recurrence using urinary vascular endothelial factor levels in patients receiving radiation therapy for Glioblastoma Multiforme (GBM). | Biomark Res | 2013 |
| 24101048 | Net clinical benefit analysis of radiation therapy oncology group 0525: a phase III trial comparing conventional adjuvant temozolomide with dose-intensive temozolomide in patients with newly diagnosed glioblastoma. | Journal of Clinical Oncology | 2013 |
| 24101040 | Dose-dense temozolomide for newly diagnosed glioblastoma: a randomized phase III clinical trial. | J Clin Oncol | 2013 |
| 20888136 | Validation and simplification of the Radiation Therapy Oncology Group recursive partitioning analysis classification for glioblastoma. | International Journal of Radiation Oncology Biology Physics | 2011 |
| 19114694 | Short delay in initiation of radiotherapy may not affect outcome of patients with glioblastoma: a secondary analysis from the radiation therapy oncology group database. | J Clin Oncol | 2009 |
| 18342381 | A phase I-B trial of the radiosensitizer: etanidazole (SR-2508) with radiosurgery for the treatment of recurrent previously irradiated primary brain tumors or brain metastases (RTOG Study 95-02). | Radiother Oncol | 2008 |
| 16443947 | Phase 2 trial of radiation plus high-dose tamoxifen for glioblastoma multiforme: RTOG protocol BR-0021. | Neuro Oncol | 2006 |
| 16750317 | A phase II trial of accelerated radiotherapy using weekly stereotactic conformal boost for supratentorial glioblastoma multiforme: RTOG 0023. | International Journal of Radiation Oncology Biology Physics | 2006 |
| 12095566 | Phase II study of topotecan plus cranial radiation for glioblastoma multiforme: results of Radiation Therapy Oncology Group 9513. | International Journal of Radiation Oncology Biology Physics | 2002 |
| 7933239 | Treatment related sequelae following external beam radiation for prostate cancer: a review with an update in patients with stages T1 and T2 tumor. | Journal of Urology | 1994 |
| 1514529 | Intraoperative radiation therapy of extrahepatic biliary carcinoma: a report of RTOG-8506. | American Journal of Clinical Oncology: Cancer Clinical Trials | 1992 |
| 1728378 | A reappraisal of the International Federation of Gynecology and Obstetrics staging system for cervical cancer. A study of patterns of care. | Cancer | 1992 |
| 2004942 | Pretreatment and treatment factors associated with improved outcome in squamous cell carcinoma of the uterine cervix: a final report of the 1973 and 1978 patterns of care studies. | International Journal of Radiation Oncology Biology Physics | 1991 |
| 1917622 | Long-term treatment sequelae following external beam irradiation for adenocarcinoma of the prostate: analysis of RTOG studies 7506 and 7706. | International Journal of Radiation Oncology Biology Physics | 1991 |
| 2249184 | The Patterns of Care Outcome Study for cancer of the uterine cervix. Results of the Second National Practice Survey. | Cancer | 1990 |
| 2604862 | Equipment and manpower needs in radiation oncology dosimetry and treatment delivery. | Medical Dosimetry | 1989 |
| 3620228 | The course of idiopathic dilated cardiomyopathy in New Zealand. | | 1987 |